Sumner Michael John

Sumner Michael John is listed in filings as Chief Medical Officer at Inovio Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including 24 public disclosures. Recent filings connect the profile to Inovio Pharmaceuticals, Inc. (INO). The current snapshot covers public activity from Jul 1, 2024 to May 21, 2026. Reported amounts are shown as $3.3K to $884. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.